Nachrichten zur BioDelivery Sciences International Aktie

Zacks.com featured highlights include: BioDelivery, Ciena, United States and Molina

Zacks.com featured highlights include: BioDelivery, Ciena, United States and Molina...…

The Zacks Analyst Blog Highlights: Middlesex Water, Atlantic Power, NexPoint Residential Trust, Illumina and BioDelivery Sciences International

The Zacks Analyst Blog Highlights: Middlesex Water, Atlantic Power, NexPoint Residential Trust, Illumina and BioDelivery Sciences International...…

BioPharma Credit makes debt investment of up to $80m in BioDelivery Sciences

Life sciences debt investor BioPharma Credit entered into a senior secured term loan agreement for up to US$80m with BioDelivery…

BioDeliverys Bang Up Quarter

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

BioDelivery Sciences International, Inc. (BDSI) CEO Herm Cukier on Q1 2019 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

BioDelivery Sciences International, Inc. (BDSI) Q1 2019 Earnings Call Transcript

BDSI earnings call for the period ending March 31, 2019....…

BioDelivery Sciences International (BDSI) Reports Q1 Loss, Tops Revenue Estimates

BioDelivery (BDSI) delivered earnings and revenue surprises of 37.50% and 0.88%, respectively, for the quarter ended March 2019. Do the…

BioDelivery (BDSI) Up 7.8% Since Last Earnings Report: Can It Continue-

BioDelivery (BDSI) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings estimates for…

BioDelivery (BDSI) Buys US Rights to Pain Drug for $30M

BioDelivery Sciences (BDSI) announces acquisition of U.S. commercial rights to pain drug, Symproic, from Japanese company, Shinogi....…

The Daily Biotech Pulse: NASH Cheer For Intercept, Gilead Layoffs, BioDelivery Licenses Constipation Drug

Heres a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week…

BioDelivery Sciences International (BDSI) Dips More Than Broader Markets: What You Should Know

BioDelivery Sciences International (BDSI) closed at $5.06 in the latest trading session, marking a -1.65% move from the prior day....…

BioDelivery Sciences International (BDSI) Gains But Lags Market: What You Should Know

BioDelivery Sciences International (BDSI) closed the most recent trading day at $5.30, moving +0.57% from the previous trading session....…

BioDelivery (BDSI) Q4 Earnings In Line, Sales Beat, Stock Up

BioDelivery Sciences (BDSI) reports in-line loss in Q4. Sales beat the consensus mark. The company issues encouraging guidance for 2019....…

BioDelivery Sciences International, Inc. (BDSI) CEO Herm Cukier on Q4 2018 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Biodelivery Sciences International Inc (BDSI) Q4 2018 Earnings Conference Call Transcript

BDSI earnings call for the period ending December 31, 2018....…

BioDelivery Sciences - Investment In Ending The Opioid Epidemic

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

What Makes BioDelivery Sciences International (BDSI) a Strong Momentum Stock: Buy Now-

Does BioDelivery Sciences International (BDSI) have what it takes to be a top stock pick for momentum investors? Lets find…

Zacks.com featured expert Kevin Matras highlights: First, Clearfield, BioDelivery Sciences International, MGIC Investment and Kratos Defense & Security Solutions

Zacks.com featured expert Kevin Matras highlights: First, Clearfield, BioDelivery Sciences International, MGIC Investment and Kratos Defense & Security Solutions...…

The Zacks Analyst Blog Highlights: BioDelivery, Cytokinetics, Celldex, Aduro and Aeterna

The Zacks Analyst Blog Highlights: BioDelivery, Cytokinetics, Celldex, Aduro and Aeterna...…

BioDelivery Sciences: The Momentum Continues To Build

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

BioDelivery Sciences International (BDSI) is a Great Momentum Stock: Should You Buy-

Does BioDelivery Sciences International (BDSI) have what it takes to be a top stock pick for momentum investors? Lets find…

Zacks.com featured highlights include: Rent-A-Center, BioDelivery , Seabridge, Marchex and DSP

Zacks.com featured highlights include: Rent-A-Center, BioDelivery , Seabridge, Marchex and DSP...…

BioDelivery Sciences Continues To Roll

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

BioDelivery (BDSI) Q3 Earnings Beat, Sales In Line, Stock Up

BioDelivery Sciences (BDSI) reports narrower-than-expected loss in Q3. Sales were almost in line with the consensus mark....…

BioDelivery Sciences Internationals (BDSI) CEO Herm Cukier on Q3 2018 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

BioDelivery Sciences International (BDSI) Reports Q3 Loss, Misses Revenue Estimates

BioDelivery (BDSI) delivered earnings and revenue surprises of 28.57% and -0.38%, respectively, for the quarter ended September 2018. Do the…

Can The Uptrend Continue for BioDelivery Sciences International (BDSI)-

Investors certainly have to be happy with BioDelivery Sciences International, Inc. (BDSI) and its short term performance....…

BioDelivery Sciences International (BDSI) Investor Presentation - Slideshow

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

BioDelivery Sciences (BDSI) Presents At Rodman & Renshaw.C. Wainwright 20th Annual Global Investment Conference - Slideshow

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

BioDeliverys (BDSI) CEO Herm Cukier on Q2 2018 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

BioDelivery Sciences International (BDSI) Reports Q2 Loss, Misses Revenue Estimates

BioDelivery (BDSI) delivered earnings and revenue surprises of 15.79% and -2.16%, respectively, for the quarter ended June 2018. Do the…

BioDelivery Sciences: Buy The Dip

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Is a Beat in Store for BioDelivery (BDSI) in Q2 Earnings-

Investor focus will be on the performance of BioDelivery Sciences (BDSI) two marketed drugs, Belbuca (chronic pain) and Bunavail (opioid-dependence)....…

BioDelivery Sciences (BDSI) Presents At William Blair 2018 Growth Stock Conference - Slideshow

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Reader Inquiry: Financing Overhang Cleared For BioDelivery Sciences - Whats Next-

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

BioDelivery Sciences International, Inc. 2018 Q1 - Results - Earnings Call Slides

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

BioDelivery (BDSI) Q1 Earnings and Sales Beat Estimates

BioDelivery Sciences (BDSI) reports narrower-than-expected loss in Q1. Sales marginally beat the consensus mark....…

Reader Inquiry: At 52-Week Lows Is BioDelivery Sciences A Viable Turnaround Play-

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

BioDelivery Sciences Internationals (BDSI) CEO Herm Cukier on Q1 2018 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

BioDelivery Sciences (BDSI) Q1 Earnings: What to Expect-

Investor focus will be on the performance of BioDelivery Sciences (BDSI) two marketed drugs, Belbuca (chronic pain) and Bunavail (opioid-dependence)....…

BRIEF-BioDelivery Sciences Appoints Herm Cukier As CEO

* BIODELIVERY SCIENCES APPOINTS HERM CUKIER AS CHIEF EXECUTIVE OFFICER...…

BRIEF-Broadfin Says Delivered Letter To BioDelivery Sciences With Nominations For Board

* BROADFIN - ON APRIL 27, DELIVERED LETTER TO BIODELIVERY SCIENCES NOMINATING TODD C. DAVIS, PETER S. GREENLEAF, STEPHEN T. WILLS FOR ELECTION…

Why Is BioDelivery Sciences (BDSI) Up 2.4% Since Its Last Earnings Report-

BioDelivery Sciences (BDSI) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings estimates…

BRIEF-Broadfin Capital Reports 7.3 Pct Stake In Biodelivery Sciences

April 10 (Reuters) - BioDelivery Sciences International Inc :...…

BioDelivery (BDSI) Q4 Loss Wider-Than-Expected, Sales Up Y/Y

BioDelivery (BDSI) reports wider-than-expected loss in Q4. However, revenues surpass estimates and increase substantially year over year....…

BioDelivery Sciences Internationals (BDSI) CEO Mark Sirgo on Q4 2017 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

BRIEF-Biodelivery Sciences Reports Q4 Loss Per Share $0.29

March 15 (Reuters) - Biodelivery Sciences International Inc :...…

Whats in the Cards for BioDelivery (BDSI) in Q4 Earnings-

BioDeliverys (BDSI) lead drugs Belbuca and Bunavail look promising to deliver an earnings beat in Q4....…

Technical Perspectives on Biotech Stocks -- BioCryst Pharma, BioDelivery Sciences, BioLine Rx, and BioTime

NEW YORK, Feb. 20, 2018 /PRNewswire/ -- WallStEquities.com strives to bring the best free research to the investment community. …

BRIEF-Biodelivery Sciences Announces Belbuca Patent Litigation Settlement Agreement With Teva

* BIODELIVERY SCIENCES ANNOUNCES BELBUCA PATENT LITIGATION SETTLEMENT AGREEMENT WITH TEVA...…